Currently, Hb level has been used as a prognostic factor in nasopharyngeal carcinoma, vulvar squamous cell carcinoma, advanced head and neck cancer, and early breast cancer.24, 27, 28, 29. This evidence concerns the gene GSTM1 and nasopharyngeal carcinoma.